Efforts to sequence various genomes have provided a wealth of new biological data, but have exacerbated a growing deficit in tools to study protein function and interrelationships. This may be particularly true in neurobiology where many new pathways have been identified, but reagents, such as antibodies, still do not exist for well-known pathway members. For example, proteins involved in the regulation of GABA are known to be important in human neurological disorders, but few antibody reagents for their study exist. To address these needs and create a means for scientists to isolate antibodies of their own choosing, we intend to create a monoclonal antibody-producing, whole cell antigen hybridoma library and antibody microarrays representative of the library. This initial library will be derived from rat brain cells, and may allow discovery of new diagnostic or therapeutic targets; future libraries can target other species or tissue types. The microarrays produced from the library will be available to scientists worldwide for individual screening; subsequent secondary screening will produce cloned novel antibodies. Thus, two major needs are served with this proposal: a renewable, screenable, and shareable source of novel research reagent antibodies, and a means of broad-based production and discovery of tissue type-specific antibodies.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43NS043817-01
Application #
6484562
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (10))
Program Officer
Grabb, Margaret C
Project Start
2002-05-07
Project End
2002-11-30
Budget Start
2002-05-07
Budget End
2002-11-30
Support Year
1
Fiscal Year
2002
Total Cost
$99,905
Indirect Cost
Name
Imgenex Corporation
Department
Type
DUNS #
023984169
City
San Diego
State
CA
Country
United States
Zip Code
92121